HDAC expression has been shown to be associated with neuroblastoma treatment resistance [93–95], and HDAC inhibitors have been previously shown to inhibit neuroblastoma cell growth and to induce differentiation, apoptosis and cell cycle arrest in neuroblastoma tumors [60]. Here, HDAC9 is linked to neuroblastoma.